2018. DEVELOPMENT AND EVALUATION OF SBA-15 MESOPOROUS SILICA NANOPARTICLES FOR BIOAVAILABILITY ENHANCEMENT OF RITONAVIR. International Research Journal of Pharmacy. 9, 3 (Mar. 2018), 13–19.